-
As 2002 comes to a close, get ready to add a new lower-dose version of a popular oral contraceptive (OC) to your list of pills, and look to the upcoming 2003 introduction of a generic form of a long-time Pill favorite.
-
In discussing condom use, your college-age male patient tells you that he uses protection on a regular basis. But is he using condoms correctly?
-
When reviewing birth control options with a teen-age female patient, she tells you that she doesnt want to use the Pill because it will make her gain weight. What do you tell her?
-
Add just-published research to your counseling on Depo-Provera (depot medroxyprogesterone acetate or DMPA): Use of the injectable contraceptive is strongly associated with bone density loss; however bone loss appears to be largely reversible once the injections are stopped.1
-
If a large segment of your patient population is using the monthly contraceptive injection Lunelle, chances are that the last few weeks have been filled with contacting patients, answering questions, and counseling on backup contraception after the manufacturer issued a voluntary recall of prefilled syringes of the product.
-
Circle the calendar now for the annual Contraceptive Technology conference. Sessions will be held March 6-8, 2008, in Boston, and April 3-5, 2008, in San Francisco.
-
The richer nations of the world have stepped up their collective response to the global AIDS pandemic, with the number of HIV-positive people in low- and middle-income countries receiving treatment increasing from 400,000 to 2 million between 2003 and 2006.
-
Good news: Recent research indicates that the human papillomavirus (HPV) vaccine Gardasil (Merck & Co.; Whitehouse Station, NJ) also provides about 40% cross-protection against other common oncogenic strains of HPV, in addition to its established strains.
-
When payday rolls around in your office, are envelopes met with grins or grimaces? For providers in family planning, 2007 proved to bring fewer smiles on the salary scene.
-
Intrauterine contraception is safe and effective, but many clinicians continue to exclude it from their list of contraceptive options.